Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Anti-Gravity Treadmill and Electromagnetic Stimulation in Stroke Rehabilitation

7. Juli 2026 aktualisiert von: BTL Industries Ltd.

Efficacy of Post-Stroke Rehabilitation Using an Anti-Gravity Treadmill and High-Intensity Electromagnetic Stimulation: A Prospective Randomized Controlled Trial

The goal of this clinical trial is to learn if adding new technologies to standard therapy helps people recover after a stroke. It looks at adults aged 18 to 74 who recently had a stroke and need help with moving and walking.

The main questions the study aims to answer are:

Does adding anti-gravity treadmill training to standard physical therapy improve balance and walking ability? Does adding high-intensity electromagnetic therapy to the treadmill program further help lower muscle stiffness and improve movement? Are these combined exercise treatments safe for the participants?

Researchers will compare three groups of participants to see which combination works best:

Group 1 receives standard physical therapy and anti-gravity treadmill training. Group 2 receives standard physical therapy, anti-gravity treadmill training, and electromagnetic therapy.

Group 3 receives standard physical therapy only.

Participants will:

Complete standard physical and daily living therapy for three to four hours a day, five days a week.

Exercise on a special treadmill that uses air pressure to support their body weight (Groups 1 and 2 only).

Receive a 15-minute electromagnetic stimulation treatment on their leg muscles 10 times over two weeks (Group 2 only).

Take movement, balance, and walking tests at the start and at the end of the two-week program.

Studienübersicht

Detaillierte Beschreibung

Background and Rationale Stroke is a leading cause of long-term disability and death worldwide. Many people who survive a stroke experience severe weakness in their limbs (62%) and difficulties with balance or walking (46%). Starting intensive, multi-disciplinary rehabilitation early is crucial to help patients maximize their recovery and regain independence. Traditional treadmill training is a powerful tool to restore walking ability, but it is often unsafe or impossible for patients who have lost significant muscle strength in their legs. This study evaluates a comprehensive rehabilitation program designed to overcome these limitations by combining two modern physical therapy technologies: an anti-gravity treadmill and high-intensity electromagnetic stimulation (HIES).

The Technologies Being Tested The Anti-Gravity Treadmill (BTL's R-FORCE): This device uses a sealed chamber with positive air pressure to gently lift the participant, supporting up to 100% of their body weight. This allows individuals to practice walking very early in their recovery without overloading weak muscles or risking a fall.

HIES (BTL-6000 Super Inductive System): This technology sends pulsed electromagnetic fields deep into neuromuscular tissues. It is used to safely lower muscle stiffness (spasticity) and improve general joint movement. While both tools are expanding in clinical use individually, this trial directly examines if integrating them into a single protocol provides a superior cumulative benefit for walking recovery and spasticity reduction.

Study Design and Participant Groups

This prospective, randomized, comparative clinical trial included 105 participants hospitalized in the acute or early recovery phase of a stroke at Samara City Clinical Hospital. All participants presented with a baseline modified Rankin Scale score of 3 to 4, indicating moderate to severe disability requiring daily assistance. Participants were randomly allocated in an equal 1:1:1 ratio into one of three parallel groups (35 individuals per group):

Group 1 (Treadmill Group): Participants received standard inpatient rehabilitation combined with specialized anti-gravity treadmill training.

Group 2 (Combined Technology Group): Participants received standard inpatient rehabilitation, anti-gravity treadmill training, and HIES.

Group 3 (Control Group): Participants received the standard inpatient rehabilitation protocol only.

What Participation Involved All three groups underwent a highly active 14-day rehabilitation program. Every participant completed approximately 3 to 4 hours of standard multidisciplinary therapy per day, 5 days a week, which included physical therapy, occupational therapy, and speech therapy as needed.

Participants in Groups 1 and 2 added tailored walking sessions on the anti-gravity treadmill to their daily routine.

Participants in Group 2 additionally received 10 sessions of HIES (5 times per week for 15 minutes per session) targeting the lower back spine and the spastic leg muscles.

Clinical and functional assessments were performed for all participants at the time of admission and again at discharge (Day 14). To ensure objective tracking, the assessments were conducted by independent medical experts who were strictly blinded to which treatment group the participants belonged to. The trial carefully monitored changes in overall neurological health, balance, walking ability, muscle stiffness, and general functional independence in daily activities.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

105

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Samara Oblast
      • Samara, Samara Oblast, Russland, 443008
        • Samara City Clinical Hospital No. 2

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Nein

Beschreibung

Inclusion Criteria:

  • verified diagnosis of ischemic or hemorrhagic stroke according to neuroimaging data (computed tomography or magnetic resonance imaging;
  • age 18 to 74 years;
  • Rankin Scale score of 3-4 upon admission;
  • ability to obtain informed consent.

Exclusion Criteria:

  • severe cognitive impairment (MoCA < 10),
  • rapidly progressive neurological deficit, unstable cardiovascular or respiratory system condition, contraindications to physical exercise.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Experimental Arm 1: Standard rehabilitation + Anti-gravity treadmill

Participants in this arm receive standard rehabilitation combined with specialized anti-gravity treadmill training.

Standard Rehabilitation: This protocol consists of daily physical therapy (focusing on limb movement training, balance, and walking exercises), occupational therapy, speech therapy as indicated, and neuropsychological sessions.

Anti-Gravity Treadmill Training: Participants undergo walking training with partial body weight support.

The total combined training amounts to approximately 3 to 4 hours per day, 5 days a week, over a 14-day early rehabilitation period.

A treadmill system that enables walking training with partial body weight support (up to 100%) by creating positive pressure in a sealed chamber housing the participant. This technology makes it possible to begin restorative walking training as early as possible after a stroke, without the risk of overloading weakened muscle groups or causing falls.
Andere Namen:
  • BTL R-FORCE
Rehabilitation consisting of daily physical therapy (limb movement training, balance, and walking exercises), occupational therapy, speech therapy as indicated, and neuropsychological sessions.
Experimental: Experimental Arm 2: Standard rehabilitation + Anti-gravity treadmill + HIES

Participants in this arm receive standard rehabilitation combined with specialized anti-gravity treadmill training and high-intensity electromagnetic stimulation (HIES).

Standard Rehabilitation: This protocol consists of daily physical therapy (focusing on limb movement training, balance, and walking exercises), occupational therapy, speech therapy as indicated, and neuropsychological sessions.

Anti-Gravity Treadmill Training: Participants undergo walking training with partial body weight support..

HIES: Participants receive 10 sessions of HIES delivered 5 times per week (15 minutes per session).

The treatment directly targets the spastic leg muscles and their antagonists, including the quadriceps femoris, calf muscles, and the lumbar spine nerve projection zone. The total training amounts to approximately 3 to 4 hours per day, 5 days a week, over a 14-day early rehabilitation period.

A treadmill system that enables walking training with partial body weight support (up to 100%) by creating positive pressure in a sealed chamber housing the participant. This technology makes it possible to begin restorative walking training as early as possible after a stroke, without the risk of overloading weakened muscle groups or causing falls.
Andere Namen:
  • BTL R-FORCE
Rehabilitation consisting of daily physical therapy (limb movement training, balance, and walking exercises), occupational therapy, speech therapy as indicated, and neuropsychological sessions.
A therapeutic device utilizing high-intensity pulsed electromagnetic fields that can penetrate deep-seated tissues to produce an antispastic effect. The treatment is applied directly to the spastic leg muscles and their antagonists to reduce muscle tone and support motor recovery.
Andere Namen:
  • Repetitive Peripheral Magnetic Stimulation
  • BTL-6000 Super Inductive System
Aktiver Komparator: Control Arm 3: Standard rehabilitation only

Participants in this arm receive the standard rehabilitation protocol only.

Standard Inpatient Rehabilitation: This protocol follows the current institutional standard care and includes scheduled physical therapy (focusing on limb movement training, balance, and walking exercises), occupational therapy, speech therapy as indicated, and neuropsychological sessions.

The total training amounts to approximately 3 to 4 hours per day, 5 days a week, over a 14-day early rehabilitation period.

Rehabilitation consisting of daily physical therapy (limb movement training, balance, and walking exercises), occupational therapy, speech therapy as indicated, and neuropsychological sessions.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change from Baseline in Rivermead Mobility Index (RMI)
Zeitfenster: Baseline (admission) and Day 14 (discharge)
The RMI assesses functional mobility (gait, balance, and transfers). The score ranges from 0 to 15, where higher scores indicate better mobility.
Baseline (admission) and Day 14 (discharge)
Change from Baseline in National Institutes of Health Stroke Scale (NIHSS) score
Zeitfenster: Baseline (admission) and Day 14 (discharge)
The NIHSS is used to measure the severity of neurological deficits. The score ranges from 0 to 42, where higher scores indicate a worse neurological status.
Baseline (admission) and Day 14 (discharge)
Change from Baseline in Functional Independence Measure (FIM)
Zeitfenster: Baseline (admission) and Day 14 (discharge)
The FIM assesses the level of a patient's physical and cognitive disability and their functional independence in daily activities. The score ranges from 18 to 126, where higher scores indicate greater functional independence.
Baseline (admission) and Day 14 (discharge)
Change from Baseline in Berg Balance Scale (BBS)
Zeitfenster: Baseline (admission) and Day 14 (discharge)
The BBS is used to objectively determine a patient's ability to safely balance during a series of predetermined tasks. The score ranges from 0 to 56, where higher scores indicate better balance.
Baseline (admission) and Day 14 (discharge)

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change from Baseline in modified Rankin Scale (mRS)
Zeitfenster: Baseline (admission) and Day 14 (discharge)
The mRS is used to measure the degree of disability or dependence in the daily activities of people who have suffered a stroke. The score ranges from 0 to 6, where lower scores indicate less disability.
Baseline (admission) and Day 14 (discharge)
Change from Baseline in Rehabilitation Routing Scale (SRM)
Zeitfenster: Baseline (admission) and Day 14 (discharge)
The SRM assesses disability and determines the appropriate rehabilitation pathway or setting. The score ranges from 0 to 6, where lower scores indicate clinical improvement (reduction in burden).
Baseline (admission) and Day 14 (discharge)
Change from Baseline in modified Ashworth Scale (mAS)
Zeitfenster: Baseline (admission) and Day 14 (discharge)
The mAS is used to assess the muscle tone and measure the increase in muscle spasticity. The score ranges from 0 to 4, where lower scores indicate a reduction in spasticity.
Baseline (admission) and Day 14 (discharge)
Change from Baseline in Hauser Ambulation Index (HAI)
Zeitfenster: Baseline (admission) and Day 14 (discharge)
The HAI is a rating scale used to evaluate mobility and walking ability, focusing on the time and degree of assistance required. The score ranges from 0 to 9, where higher scores indicate worse walking status.
Baseline (admission) and Day 14 (discharge)

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. Januar 2026

Primärer Abschluss (Tatsächlich)

31. Mai 2026

Studienabschluss (Tatsächlich)

31. Mai 2026

Studienanmeldedaten

Zuerst eingereicht

7. Juli 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

7. Juli 2026

Zuerst gepostet (Tatsächlich)

13. Juli 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

13. Juli 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

7. Juli 2026

Zuletzt verifiziert

1. Juli 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

Anonymized individual participant data will be shared as supporting information files directly with the journal publication.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Anti-Gravity Treadmill

3
Abonnieren